JBGlobal.com’s Pfizer PFE Stock Holding History

JBGlobal.com’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-9,827	Closed	-$250K	–	26
2025 Q3	$250K	Buy	9,827 +1	+0%	+$25	0.26%	25
2025 Q2	$238K	Sell	9,826 -6,629	-40%	-$155K	0.25%	27
2025 Q1	$417K	Buy	16,455 +2,816	+21%	+$73.7K	0.43%	21
2024 Q4	$362K	Buy	+13,639	New	+$370K	0.38%	23

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JBGlobal.com's PFE Position: Q4 2025 in Review

JBGlobal.com sold out of Pfizer (PFE) in Q4 2025, closing a stake of 9,827 shares — an estimated $250K sold.

JBGlobal.com first reported a position in PFE in Q4 2024 and held it in 4 quarters. The position peaked at $417K in Q1 2025. 2,915 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

JBGlobal.com reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
JBGlobal.com sold 9,827 Pfizer shares in Q4 2025, an estimated $250K.
JBGlobal.com first reported a position in Pfizer in Q4 2024 and held it in 4 quarters.
JBGlobal.com's Pfizer position peaked at $417K in Q1 2025.
2,915 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on JBGlobal.com's 13F filing for Q4 2025, filed 6 Jan 2026.